Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-13

Clinical Trial Update: Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma (SWITCH)

View source ↗

Summary

Clinical SWITCH trial examines surgery versus watch-and-wait in complete responders with hepatocellular carcinoma; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: West China Hospital | Conditions: HCC - Hepatocellular Carcinoma, Watch & Wait | Status: NOT_YET_RECRUITING